AMED Logo

Amedisys, Inc. (AMED) 

NASDAQ$92.38
Market Cap
$3.03B
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
445 of 922
Rank in Industry
22 of 44

AMED Insider Trading Activity

AMED Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$000
Sells
$187,8331100

Related Transactions

Guidroz AllysonChief Accounting Officer0$01$187,833$-187,833

About Amedisys, Inc.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Insider Activity of Amedisys, Inc.

Over the last 12 months, insiders at Amedisys, Inc. have bought $0 and sold $187,833 worth of Amedisys, Inc. stock.

On average, over the past 5 years, insiders at Amedisys, Inc. have bought $367,793 and sold $5.23M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,000 shares for transaction amount of $141,250 was made by LECHLEITER RICHARD A (director) on 2021‑11‑30.

List of Insider Buy and Sell Transactions, Amedisys, Inc.

2025-03-04SaleGuidroz AllysonChief Accounting Officer
2,041
0.0062%
$92.03$187,833+0.29%
2023-03-03SaleNorth Michael PaulChief Information Officer
5,908
0.0176%
$86.43$510,628+4.04%
2022-06-23SaleBohnert Denise M.Chief Compliance Officer
557
0.0017%
$115.00$64,055-20.74%
2022-03-29SaleKemmerly David LSee Remarks
443
0.0014%
$177.89$78,805-42.41%
2021-11-30PurchaseLECHLEITER RICHARD Adirector
1,000
0.0031%
$141.25$141,250-11.92%
2021-09-01SalePERKINS BRUCE Ddirector
11,511
0.0351%
$183.00$2.11M-21.80%
2021-08-02SaleGerard ChristopherPresident & COO
1,250
0.0039%
$261.24$326,544-41.61%
2021-07-01SaleGerard ChristopherPresident & COO
1,250
0.0037%
$250.90$313,622-39.89%
2021-06-01SaleGerard ChristopherPresident & COO
1,250
0.0038%
$256.62$320,771-37.28%
2021-05-28SaleGinn Scott GEVP & Chief Financial Officer
975
0.003%
$261.60$255,060-36.89%
2021-05-25SaleGerard ChristopherPresident & COO
1,250
0.0038%
$259.59$324,488-36.86%
2021-04-30SaleGinn Scott GEVP & Chief Financial Officer
975
0.0031%
$283.33$276,247-37.99%
2021-04-27SaleKemmerly David LSee Remarks
4,875
0.0152%
$290.12$1.41M-41.17%
2021-04-27SaleNorth Michael PaulChief Information Officer
1,731
0.0054%
$290.02$502,025-41.17%
2021-04-09SaleKemmerly David LSee Remarks
500
0.0015%
$280.00$140,000-39.55%
2021-04-01SaleKemmerly David LSee Remarks
503
0.0015%
$270.00$135,810-35.48%
2021-03-31SaleGinn Scott GEVP & Chief Financial Officer
975
0.0029%
$260.40$253,890-34.28%
2021-03-01PurchasePERKINS BRUCE Ddirector
1,000
0.0031%
$259.38$259,376-28.36%
2021-02-26SaleGinn Scott GEVP & Chief Financial Officer
975
0.0031%
$264.15$257,546-27.86%
2021-02-25SaleBohnert Denise M.Chief Compliance Officer
70
0.0002%
$274.44$19,211-30.40%
Total: 310
*Gray background shows transactions not older than one year

Insider Historical Profitability

59.41%
Guidroz AllysonChief Accounting Officer
8761
0.0267%
$809,341.1801
NORTH TIDE CAPITAL, LLC10 percent owner
3313300
10.0984%
$306.08M46+82.32%
NIERENBERG DAVID10 percent owner
1222543
3.7261%
$112.94M226+147.9%
RICCHIUTI PETERdirector
76600
0.2335%
$7.08M330+22.74%
NETTERVILLE JAKE Ldirector
71700
0.2185%
$6.62M414+15.82%
PITTS DAVID Rdirector
54608
0.1664%
$5.04M32+17.89%
BORNE WILLIAM FChief Executive Officer /
38988
0.1188%
$3.6M318+19.09%
Gerard ChristopherPresident & COO
37856
0.1154%
$3.5M023
WASHBURN DONALD Adirector
36698
0.1118%
$3.39M42+20.91%
JETER JEFFREY DChief Compliance Officer
33579
0.1023%
$3.1M08
Ginn Scott GEVP & Chief Financial Officer
29109
0.0887%
$2.69M021
KKR Credit Advisors (US) LLC10 percent owner
22933
0.0699%
$2.12M111+0.42%
REDMAN DALE EChief Financial Officer
18504
0.0564%
$1.71M10+14.26%
PERKINS BRUCE Ddirector
17869
0.0545%
$1.65M91+14.8%
Pernosky Lawrence RChief Human Resources Officer
17812
0.0543%
$1.65M03
Fleming Michael O.Chief Medical Officer
17728
0.054%
$1.64M01
Brunecz SharonChief Human Resources Officer
17733
0.054%
$1.64M04
Hall Linda J.director
17169
0.0523%
$1.59M04
Kemmerly David LSee Remarks
16336
0.0498%
$1.51M019
LABORDE RONALD Adirector
15520
0.0473%
$1.43M012
Bohnert Denise M.Chief Compliance Officer
11850
0.0361%
$1.09M07
LECHLEITER RICHARD Adirector
9368
0.0286%
$865,415.8410<0.0001%
Klapstein Julie Ddirector
7993
0.0244%
$738,393.3402
Pearce David B.Chief Compliance Officer
5525
0.0168%
$510,399.5008
GRAHAM LARRY RCOO and President
4877
0.0149%
$450,537.26116+24.7%
North Michael PaulChief Information Officer
4164
0.0127%
$384,670.32013
BROWNE GREGORY HChief Financial Officer
2301
0.007%
$212,566.3805
Schwartz Alice AChief Information Officer
2022
0.0062%
$186,792.3616+10.37%
CAPPS VICKIE Ldirector
1780
0.0054%
$164,436.4010+25.9%
Kline Teresa L.director
1780
0.0054%
$164,436.4010+72.38%
Rideout Jeffrey Adirector
1297
0.004%
$119,816.8605
Bucey David RGeneral Counsel and Secretary
0
0%
$021+17.78%
*Gray background shows insiders who have made transactions during last year

AMED Institutional Investors: Active Positions

Increased Positions157+51.14%6M+21.38%
Decreased Positions129-42.02%5M-17.02%
New Positions54New3MNew
Sold Out Positions47Sold Out2MSold Out
Total Postitions335+9.12%30M+4.36%

AMED Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$297,716.009.75%3.22M+10,817+0.34%2024-12-31
Blackrock, Inc.$296,545.009.71%3.2M+134,924+4.4%2024-12-31
Fil Ltd$115,713.003.79%1.25M-59,623-4.55%2024-12-31
Pentwater Capital Management Lp$109,233.003.58%1.18M+105,000+9.77%2024-12-31
State Street Corp$91,992.003.01%993,761+43,201+4.54%2024-12-31
Norges Bank$84,689.002.77%914,864+525,471+134.95%2024-12-31
Alpine Associates Management Inc.$82,213.002.69%888,120+27,403+3.18%2024-12-31
Citadel Advisors Llc$80,810.002.65%872,962+268,661+44.46%2024-12-31
Wealthfront Advisers Llc$74,401.002.44%803,727+803,727New2024-12-31
Tig Advisors, Llc$65,763.002.15%710,415+710,415New2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.